Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M957Revenue (TTM) $M908Net Margin (%)-19.9Altman Z-Score1.2
Enterprise Value $M2,001EPS (TTM) $-2.5Operating Margin %-22.0Piotroski F-Score3
P/E(ttm)--Beneish M-Score-2.0Pre-tax Margin (%)-32.2Higher ROA y-yN
Price/Book1.010-y EBITDA Growth Rate %--Quick Ratio1.6Cash flow > EarningsY
Price/Sales1.05-y EBITDA Growth Rate %-13.4Current Ratio2.1Lower Leverage y-yN
Price/Free Cash Flow10.4y-y EBITDA Growth Rate %-239.5ROA % (ttm)-9.3Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-17.6Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M73.9ROIC % (ttm)-10.0Gross Margin Increase y-yN

Gurus Latest Trades with IPXL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IPXLNWQ Managers 2016-09-30 Add0.31%$21.72 - $31.62
($26.88)
$ 12.95-52%Add 473.37%1,068,795
IPXLJoel Greenblatt 2016-09-30 Sold Out -0.25%$21.72 - $31.62
($26.88)
$ 12.95-52%Sold Out0
IPXLJoel Greenblatt 2016-06-30 Add0.09%$28.01 - $36.4
($32.59)
$ 12.95-60%Add 53.33%733,848
IPXLNWQ Managers 2016-06-30 Reduce$28.01 - $36.4
($32.59)
$ 12.95-60%Reduce -2.23%186,406
IPXLJoel Greenblatt 2016-03-31 Add0.16%$30.73 - $42.76
($35.27)
$ 12.95-63%Add 2317.15%478,620
IPXLNWQ Managers 2016-03-31 Reduce-0.01%$30.73 - $42.76
($35.27)
$ 12.95-63%Reduce -3.89%190,660
IPXLNWQ Managers 2015-12-31 Reduce-0.21%$34.53 - $44.76
($40.13)
$ 12.95-68%Reduce -66.75%198,378
IPXLJoel Greenblatt 2015-12-31 Buy 0.01%$34.53 - $44.76
($40.13)
$ 12.95-68%New holding19,801
IPXLNWQ Managers 2015-09-30 Reduce-0.07%$33.27 - $50.42
($45.1)
$ 12.95-71%Reduce -16.00%596,619
IPXLNWQ Managers 2015-06-30 Reduce-0.13%$44.44 - $51.31
($47.45)
$ 12.95-73%Reduce -24.12%710,302
IPXLGeorge Soros 2015-06-30 Sold Out -0.03%$44.44 - $51.31
($47.45)
$ 12.95-73%Sold Out0
IPXLGeorge Soros 2015-03-31 Buy 0.03%$30.2 - $47.3
($39.79)
$ 12.95-67%New holding61,206
IPXLJoel Greenblatt 2015-03-31 Sold Out -0.02%$30.2 - $47.3
($39.79)
$ 12.95-67%Sold Out0
IPXLNWQ Managers 2015-03-31 Add0.02%$30.2 - $47.3
($39.79)
$ 12.95-67%Add 3.32%936,127
IPXLMario Gabelli 2015-03-31 Sold Out -0.0011%$30.2 - $47.3
($39.79)
$ 12.95-67%Sold Out0
IPXLNWQ Managers 2014-12-31 Reduce-0.1%$23.63 - $32.75
($29.3)
$ 12.95-56%Reduce -30.25%906,043
IPXLJoel Greenblatt 2014-12-31 Add0.01%$23.63 - $32.75
($29.4)
$ 12.95-56%Add 136.17%79,609
IPXLMario Gabelli 2014-12-31 Buy $23.63 - $32.75
($29.3)
$ 12.95-56%New holding6,775
IPXLNWQ Managers 2014-09-30 Add0.08%$22.77 - $30.68
($25.55)
$ 12.95-49%Add 31.90%1,298,995
IPXLJoel Greenblatt 2014-09-30 Buy 0.01%$22.77 - $30.68
($25.55)
$ 12.95-49%New holding33,709
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IPXL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IPXL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BENET LESLIE ZDirector 2016-08-15Sell10,092$22.81-43.23view
SCHLOSSBERG MARK ASVP and General Counsel 2015-09-11Sell7,457$43.3-70.09view
NESTOR MICHAELPresident, Impax Pharm. 2015-09-10Sell5,000$43.56-70.27view
FLEMING NIGELDirector 2015-08-31Sell29,166$41.02-68.43view
MARKBREITER MICHAELDirector 2015-08-31Sell28,000$41.7-68.94view
BENET LESLIE ZDirector 2015-08-31Sell20,000$40.92-68.35view
SCHLOSSBERG MARK ASVP and General Counsel 2015-08-27Sell4,649$43.41-70.17view
TERRERI PETER RDirector 2015-08-27Sell4,833$43.93-70.52view
MARKBREITER MICHAELDirector 2015-08-26Sell19,399$42.24-69.34view
HSU LARRYDirector 2014-06-06Sell100,000$28.38-54.37view

Quarterly/Annual Reports about IPXL:

News about IPXL:

Articles On GuruFocus.com
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
Alan Fournier Makes Modest Reductions in Middleby and Priceline Jan 12 2016 
Allergan Among Health Care Holdings in Alan Fournier's Portfolio Dec 15 2015 
Pharmaceutical Stocks Hold Prominent Positions in Kyle Bass' 3rd-Quarter Activity Nov 27 2015 
Kyle Bass Goes Fishing for These 3 New Holdings Nov 26 2015 
Alan Fournier's Highest Performing Stocks Jul 15 2015 
Alan Fournier's Most Heavily Weighted Trades In Q1 2015 May 28 2015 
Impax Laboratories Inc. Steps Into Profitable Zone Feb 26 2015 
President and CEO of Impax Laboratories Inc. (IPXL) Larry Hsu Bought 10,000 Shares Aug 17 2011 

More From Other Websites
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Impax... Dec 07 2016
Bragar Eagel & Squire, P.C. Announces That a Class Action Lawsuit Has Been Filed Against Impax... Dec 07 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Impax Laboratories,... Dec 07 2016
IPXL INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving... Dec 07 2016
SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline in Class Action Lawsuit... Dec 06 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against... Dec 05 2016
Blog Coverage Shire Announced Successful Results of its Phase III Investigational Study of... Dec 05 2016
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investments Impax... Dec 02 2016
Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Impax Laboratories, Inc.... Dec 02 2016
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Impax Laboratories, Inc. of a Class... Dec 02 2016
INVESTOR ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Impax... Dec 01 2016
INVESTOR ALERT: Law Offices of Howard G. Smith Commences Investigation on Behalf of Impax... Dec 01 2016
Impax Laboratories Inc. Shareholder Alert: Former SEC Attorney Willie Briscoe and Powers Taylor... Dec 01 2016
SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Impax... Dec 01 2016
Lifshitz & Miller Law Firm Announces Investigation of Adeptus Health Inc., Avid Technology, Inc.,... Dec 01 2016
SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against Impax... Nov 29 2016
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Class Action Against... Nov 29 2016
Kessler Topaz Meltzer & Check, LLP Reminds Impax Laboratories, Inc. Shareholders of Important... Nov 29 2016
IMPAX LABORATORIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to... Nov 28 2016
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Impax Laboratories,... Nov 28 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)